Sarcopenia or muscle modifications in neurologic diseases: A lexical or patophysiological difference?

European Journal of Physical and Rehabilitation Medicine

Volumn 49, Issue 1, 2013, Pages 119-130

  Carda, S ^a   Cisari, C ^b,c   Invernizzi, M ^b,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c Società Italianaper lo Studio delle Disabilità Muscolo Scheletriche   (Italy)

Author keywords

Atrophic; Central nervous system diseases; Muscular diseases; Sarcopenia; Spinal cord injuries; Stroke

Indexed keywords

AGED; AGING; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; GERIATRIC ASSESSMENT; HUMAN; INCIDENCE; MALE; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; SARCOPENIA; SPINAL CORD INJURY; TREATMENT OUTCOME; VERY ELDERLY; WALKING DIFFICULTY;

AGED; AGED, 80 AND OVER; AGING; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE PROGRESSION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INCIDENCE; MALE; MOBILITY LIMITATION; MUSCLE WEAKNESS; PROGNOSIS; RISK ASSESSMENT; SARCOPENIA; SPINAL CORD INJURIES; STROKE; TREATMENT OUTCOME;

EID: 84878646359     PISSN: 19739087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Rosenberg IH. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989;50:1231-3.
2. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889-96. (Pubitemid 34496687)
3. Bijlsma AY, Meskers CGM, Westendorp RG, Maier AB. Chronology of age-related disease definitions: osteoporosis and sarcopenia. Ageing Res Rev 2012;11:320-4.
4. Cruz-jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-23
5. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000;55:M221-31. (Pubitemid 30257618)
6. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 2011;12:403-9.
7. Adamson J, Beswick A, Ebrahim S. Is stroke the most common cause of disability? J Stroke Cerebrovasc Dis 2004;13:171-7. (Pubitemid 39349462)
8. Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D'Agostino RB, Wolf PA. The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis 2003;12:119-26. (Pubitemid 36870484)
9. Bernhardt J, Dewey H, Thrift A, Donnan G. Inactive and alone: physical activity within the first 14 days of acute stroke unit care. Stroke 2004;35:1005-9. (Pubitemid 38419818)
10. Shackelford LC, Le Blanc AD, Driscoll TB, Evans HJ, Rianon NJ, Smith SM et al. Resistance exercise as a countermeasure to disuse-induced bone loss. J Appl Physiol 2004;97:119-29. (Pubitemid 38802510)
11. Alkner BrA, Tesch PA. Knee extensor and plantar flexor muscle size and function following 90 days of bed rest with or without resistance exercise. European Journal of Applied Physiology 2004;93:294-305. (Pubitemid 39534632)
12. De Boer MD, Selby A, Atherton P, Smith K, Seynnes OR, Maganaris CN et al. The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse. J Physiol 2007;585:241-51. (Pubitemid 350131116)
13. Chokroverty S, Reyes MG, Rubino FA, Barron KD. Hemiplegic amyotrophy. Muscle and motor point biopsy study. Arch Neurol 1976;33:104-10.
14. Frontera WR, Grimby L, Larsson L. Firing rate of the lower motoneuron and contractile properties of its muscle fibers after upper motoneuron lesion in man. Muscle Nerve 1997;20:938-47. (Pubitemid 27306504)
15. Hachisuka K, Umezu Y, Ogata H. Disuse muscle atrophy of lower limbs in hemiplegic patients. Arch Phys Med Rehabil 1997;78:13-8. (Pubitemid 27034238)
16. Jakobsson F, Edstrom L, Grimby L, Thornell LE. Disuse of anterior tibial muscle during locomotion and increased proportion of type II fibres in hemiplegia. J Neurol Sci 1991;105:49-56.
17. Scelsi R, Lotta S, Lommi G, Poggi P, Marchetti C. Hemiplegic atrophy. Morphological findings in the anterior tibial muscle of patients with cerebral vascular accidents. Acta Neuropathol 1984;62:324-31. (Pubitemid 14190141)
18. Pette D, Staron SS. Myosin isoforms, muscle fiber types, and transitions. Microsc Res Tech 2000;50:500-9.
19. De Deyne PG, Hafer-Macko CE, Ivey FM, Ryan AS, Macko RF. Muscle molecular phenotype after stroke is associated with gait speed. Muscle Nerve 2004;30:209-15. (Pubitemid 38982226)
20. Ryan AS, Dobrovolny CL, Smith GV, Silver KH, Macko RF. Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Arch Phys Med Rehabil 2002;83:1703-7. (Pubitemid 35424690)
21. Ramnemark A, Nyberg L, Lorentzon R, Olsson T, Gustafson Y. Hemiosteoporosis after severe stroke, independent of changes in body composition and weight. Stroke 1999;30:755-60. (Pubitemid 29156363)
22. Jorgensen L, Jacobsen BK. Changes in muscle mass, fat mass, and bone mineral content in the legs after stroke: a 1 year prospective study. Bone 2001;28:655-9. (Pubitemid 32577383)
23. Carin-Levy G, Greig C, Young A, Lewis S, Hannan J, Mead G. Longitudinal changes in muscle strength and mass after acute stroke. Cerebrovasc Dis 2006;21:201-7.
24. Plank LD. Dual-energy X-ray absorptiometry and body composition. Curr Opin Clin Nutr Metab Care 2005;8:305-9. (Pubitemid 40586190)
25. Provyn S, Clarys JP, Wallace J, Scafoglieri A, Reilly T. Quality control, accuracy, and prediction capacity of dual energy X-ray absorptiometry variables and data acquisition. J Physiol Anthropol 2008;27:317-23.
26. Santos DA, Silva AM, Matias CN, Fields DA, Heymsfield SB, Sardinha LB. Accuracy of DXA in estimating body composition changes in elite athletes using a four compartment model as the reference method. Nutr Metab (Lond) 2010;7:22.
27. Ryan AS, Buscemi A, Forrester L, Hafer-Macko CE, Ivey FM. Atrophy and intramuscular fat in specific muscles of the thigh: associated weakness and hyperinsulinemia in stroke survivors. Neurorehabil Neural Repair 2011;25:865-72.
28. Hafer-Macko CE, Ryan AS, Ivey FM, Macko RF. Skeletal muscle changes after hemiparetic stroke and potential beneficial effects of exercise intervention strategies. J Rehabil Res Dev 2008;45:261-72.
29. Gracies JM. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005;31:535-51.
30. Dupont Salter AC, Richmond FJ, Loeb GE. Effects of muscle immobilization at different lengths on tetrodotoxin-induced disuse atrophy. IEEE Trans Neural Syst Rehabil Eng 2003;11:209-17. (Pubitemid 37187175)
31. Williams PE, Goldspink G. Changes in sarcomere length and physiological properties in immobilized muscle. J Anat 1978;127:459-68. (Pubitemid 9091904)
32. Williams PE, Goldspink G. Connective tissue changes in immobilised muscle. J Anat 1984;138(Pt 2):343-50. (Pubitemid 14125067)
33. Veldhuizen JW, Verstappen FT, Vroemen JP, Kuipers H, Greep JM. Functional and morphological adaptations following four weeks of knee immobilization. Int J Sports Med 1993;14:283-7. (Pubitemid 23232443)
34. Jackman RW. The molecular basis of skeletal muscle atrophy. AJP: Cell Physiology 2004;287:C834-C43.
35. De Boer MD, Maganaris CN, Seynnes OR, Rennie MJ, Narici MV. Time course of muscular, neural and tendinous adaptations to 23 day unilateral lower-limb suspension in young men. J Physiol 2007;583:1079-91. (Pubitemid 47423718)
36. Grimby G, Broberg C, Krotkiewska I, Krotkiewski M. Muscle fiber composition in patients with traumatic cord lesion. Scand J Rehab Med 1976;8:37-42.
37. Burnham R, Martin T, Stein R, Bell G, MacLean I, Steadward R. Skeletal muscle fibre type transformation following spinal cord injury. Spinal Cord 1997;35:86-91. (Pubitemid 27084735)
38. Scelsi R, Marchetti C, Poggi P, Lotta S, Lommi G. Muscle fiber type morphology and distribution in paraplegic patients with traumatic cord lesion. Histochemical and ultrastructural aspects of rectus femoris muscle. Acta Neuropathol 1982;57:243-8. (Pubitemid 12051353)
39. Lotta S, Scelsi R, Alfonsi E, Saitta A, Nicolotti D, Epifani P et al. Morphometric and neurophysiological analysis of skeletal muscle in paraplegic patients with traumatic cord lesion. Paraplegia 1991;29:247-52.
40. Castro MJ, Apple DF, Jr., Hillegass EA, Dudley GA. Influence of complete spinal cord injury on skeletal muscle cross-sectional area within the first 6 months of injury. Eur J Appl Physiol Occup Physiol 1999;80:373-8. (Pubitemid 29405672)
41. Andersen JL, Mohr T, Biering-Sorensen F, Galbo H, Kjaer M. Myosin heavy chain isoform transformation in single fibres from m. vastus lateralis in spinal cord injured individuals: effects of long-term functional electrical stimulation (FES). Pflugers Arch 1996;431:513-8.
42. Round JM, Barr FM, Moffat B, Jones DA. Fibre areas and histochemical fibre types in the quadriceps muscle of paraplegic subjects. J Neurol Sci 1993;110:207-11. (Pubitemid 23176858)
43. Rochester L, Barron MJ, Chandler CS, Sutton RA, Miller S, Johnson MA. Influence of electrical stimulation of the tibialis anterior muscle in paraplegic subjects. 2. Morphological and histochemical properties. Paraplegia 1995;33:514-22.
44. Schantz P, Sjoberg B, Widebeck AM, Ekblom B. Skeletal muscle of trained and untrained paraplegics and tetraplegics. Acta Physiol Scand 1997;161:31-9. (Pubitemid 27385418)
45. Gerrits HL, Hopman MTE, Offringa C, Engelen BG, Sargeant AJ, Jones DA et al. Variability in fibre properties in paralysed human quadriceps muscles and effects of training. Pflugers Arch 2003;445:734-40. (Pubitemid 36403367)
46. Widrick JJ, Norenberg KM, Romatowski JG, Blaser CA, Karhanek M, Sherwood J et al. Force-velocity-power and forcepCa relationships of human soleus fibers after 17 days of bed rest. J Appl Physiol 1998;85:1949-56. (Pubitemid 28516434)
47. Widrick JJ, Romatowski JG, Norenberg KM, Knuth ST, Bain JL, Riley DA et al. Functional properties of slow and fast gastrocnemius fibers after 17-day spaceflight. J Appl Physiol 2001;90:2203-11. (Pubitemid 32467413)
48. Taylor PN, Ewins DJ, Fox B, Grundy D, Swain ID. Limb blood flow, cardiac output and quadriceps muscle bulk following spinal cord injury and the effect of training for the Odstock functional electrical stimulation standing system. Paraplegia 1993;31:303-10. (Pubitemid 23262623)
49. Peckham PH, Mortimer JT, Masrsolais EB. Upper and lower motor neuron lesions in the upper extremity muscles of tetraplegics. Paraplegia 1976;14:115-21.
50. Gorgey AS, Dudley GA. Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury. Spinal Cord 2007;45:304-9. (Pubitemid 46572861)
51. Kern H, Boncompagni S, Rossini K, Mayr W, Fano G, Zanin ME et al. Long-term denervation in humans causes degenration of both contractile and excitation-contraction coupling apparatus, which is reversible by functional electrical stimulation (FES): a role for myofiber regeneration? J Neuropathol Exp Neurol 2004;63:919-31. (Pubitemid 39202495)
52. Shah PK, Stevens JE, Gregory CM, Pathare NC, Jayaraman A, Bickel SC et al. Lower-extremity muscle cross-sectional area after incomplete spinal cord injury. Arch Phys Med Rehabil 2006;87:772-8. (Pubitemid 43767715)
53. Schiaffino S, Mammucari C. Regulation of skeletal muscle growth by the IGFl-Akt/PKB pathway: insights from genetic models. Skeletal Muscle 2011;1:4.
54. Zhang P, Chen X, Fan M. Signaling mechanisms involved in disuse muscle atrophy. Med Hypotheses 2007;69:310-21. (Pubitemid 46818689)
55. Glass DJ. Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 2010;13:225-9.
56. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 1998;95:14938-43. (Pubitemid 29003735)
57. Von Haehling S, Lainscak M, Springer J, Anker SD. Cardiac cachexia: A systematic overview. Pharmacol Therapeut 2009;121:227-52.
58. Jones SW, Hill RJ, Krasney PA, O'Conner B, Peirce N, Greenhaff PL. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 2004;18:1025-7. (Pubitemid 39561513)
59. Heinemeier KM, Olesen JL, Schjerling P, Haddad F, Langberg H, Baldwin KM et al. Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types. J Appl Physiol 2007;102:573-81. (Pubitemid 46220885)
60. Ryan AS, Ivey FM, Prior S, Li G, Hafer-Macko C. Skeletal muscle hypertrophy and muscle myostatin reduction after resistive training in stroke survivors. Stroke 2011;42:416-20.
61. McMahon CD, O'Popovic L, Odham JM, Jeanplong F, Smith HK, Kambadur R et al. Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab 2003;285:E82-E7. (Pubitemid 36736364)
62. Leger B, Senese R, Al-Khodairy AW, Deriaz O, Gobelet C, Giacobino JP et al. Atrogin-1, MuRFl, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve 2009;40:69-78.
63. Stevenson EJ, Giresi PG, Koncarevic A, Kandarian SC. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. The Journal of Physiology 2003;551:33-48. (Pubitemid 37062910)
64. Hunter RB, Stevenson E, Koncarevic A, Mitchell-Felton H, Essig DA, Kandarian SC. Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J 2002;16:529-38. (Pubitemid 34273236)
65. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG et al. IKKβ/NF-γB Activation Causes Severe Muscle Wasting in Mice. Cell 2004;119:285-98. (Pubitemid 39360909)
66. Dogra C, Changotra H, Wedhas N, Qin X, Wergedal JE, Kumar A. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. The FASEB Journal 2007;21:1857-69. (Pubitemid 46855631)
67. Hafer-Macko CE, Yu S, Ryan AS, Ivey FM, Macko RE Elevated tumor necrosis factor-alpha in skeletal muscle after stroke. Stroke 2005;36:2021-3. (Pubitemid 41266546)
68. Von Walden F, Jakobsson F, Edstrom L, Nader GA. Altered autophagy gene expression and persistent atrophy suggest impaired remodeling in chronic hemiplegic human skeletal muscle. Muscle Nerve 2012;46:785-92.
69. Lawler JM, Song M, Demaree SR. Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle. Free Radic Biol Med 2003;35:9-16. (Pubitemid 36782333)
70. Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kB activation in response to tumor necrosis factor a. FASEB J 1998;12:871-80. (Pubitemid 28294677)
71. Furukawa-Hibi Y, Yoshida-Araki K, Ohta T, Ikeda K, Motoyama N. FOXO forkhead transcription factors induce G2-M checkpoint in response to oxidative stress. J Biol Chem 2002;277:26729-32. (Pubitemid 34951676)
72. Smuder AJ, Kavazis AN, Min K, Powers SK. Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle. J Appl Physiol 2011;110:935-42.
73. Romanello V, Guadagnin E, Gomes L, Roder I, Sandri C, Petersen Y et al. Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J 2010;29:1774-85.
74. Powers SK, Hudson MB, Nelson WB, Talbert EE, Min K, Szeto HH et al. Mitochondria-targeted antioxidants protect against mechanical ventilation-induced diaphragm weakness. Crit Care Med 2011;39:1749-59.
75. Min K, Smuder AJ, Kwon OS, Kavazis AN, Szeto HH, Powers SK. Mitochondrial-targeted antioxidants protect skeletal muscle against immobilization-induced muscle atrophy. J Appl Physiol 2011;111:1459-66.
76. Mammucari C, Schiaffino S, Sandri M. Downstream of Akt. Autophagy 2008;4:524-6.
77. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002;82:373-428. (Pubitemid 34654457)
78. Jagoe TR, Goldberg AL. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 2001;4:183-90. (Pubitemid 33682075)
79. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001;294:1704-8. (Pubitemid 33104839)
80. Chen YW, Gregory CM, Scarborough MT, Shi R, Walter GA, Vandenborne K. Transcriptional pathways associated with skeletal muscle disuse atrophy in humans. Physiol Genomics 2007;31:510-20. (Pubitemid 350127790)
81. Gustafsson T, Osterlund T, Flanagan JN, Von Walden F, Trappe TA, Linnehan RM et al. Effects of 3 days unloading on molecular regulators of muscle size in humans. J Appl Physiol 2010;109:721-7.
82. Sakuma K, Watanabe K, Hotta N, Koike T, Ishida K, Katayama K et al. The adaptive responses in several mediators linked with hypertrophy and atrophy of skeletal muscle after lower limb unloading in humans. Acta Physiol (Oxf) 2009;197:151-9.
83. Glass DJ. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 2003;5:87-90. (Pubitemid 36204186)
84. Suetta C, Frandsen U, Jensen L, Jensen MM, Jespersen JG, Hvid LG et al. Aging affects the transcriptional regulation of human skeletal muscle disuse atrophy. PLoS One 2012;7:e51238.
85. Ikemoto M, Nikawa T, Takeda S, Watanabe C, Kitano T, Baldwin KM et al. Space shuttle flight (STS-90) enhances degradation of rat myosin heavy chain in association with activation of ubiquitin-protea-some pathway. FASEB J 2001;15:1279-81.
86. Huang J, Forsberg NE. Role of calpain in skeletal-muscle protein degradation. Proc Natl Acad Sci U S A 1998;95:12100-5. (Pubitemid 28483725)
87. Tidball JG, Spencer MJ. Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expres-sion during murine muscle disuse. J Physiol 2002;545:819-28. (Pubitemid 36024422)
88. Drummond MJ, Glynn EL, Lujan HL, Dicarlo SE, Rasmussen BB. Gene and protein expression associated with protein synthesis and breakdown in paraplegic skeletal muscle. Muscle Nerve 2008;37:505-13.
89. Leger B, Senese R, Al-Khodairy AW, Deriaz O, Gobelet C, Giacobino JP et al. Atrogin-1, MuRFl, and FoXO, as well as phosphorylated GSK-3P and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve 2009;40:69-78.
90. Urso ML, Chen YW, Scrimgeour AG, Lee PC, Lee KF, Clarkson PM. Alterations in mRNA expression and protein products following spinal cord injury in humans. J Physiol 2007;579:877-92. (Pubitemid 46404366)
91. Leger B, Vergani L, Sorarù G, Hespel P, Derave W, Gobelet C et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 2006;20:583-5. (Pubitemid 46671257)
92. Bikle DD. Integrins, insulin like growth factors, and the skeletal response to load. Osteoporos Int 2008;19:1237-46.
93. Spangenburg EE, Le Roith D, Ward CW, Bodine SC. A functional insulin-like growth factor receptor is not necessary for loadinduced skeletal muscle hypertrophy. J Physiol 2008;586:283-91.
94. Homberger TA, Chu WK, Mak YW, Hsiung JW, Huang SA, Chien S. The role of phospholipase D and phosphatide acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc Natl Acad Sci U S A 2006;103:4741-6.
95. O'Neil TK, Duffy LR, Frey JW, Homberger TA. The role of phosphoinositide 3-kinase and phosphatide acid in the regulation of mammalian target of rapamycin following eccentric contractions. The Journal of Physiology 2009;587:3691-701.
96. Roig M, O'Brien K, Kirk G, Murray R, McKinnon P, Shadgan B et al. The effects of eccentric versus concentric resistance training on muscle strength and mass in healthy adults: a systematic review with meta-analysis. Br J Sports Med 2009;43:556-68.
97. Kim JS, Cross JM, Bamman MM. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol Endocrinol Metab 2005;288:E1110-9. (Pubitemid 40726797)
98. Gordon T, Mao J. Muscle atrophy and procedures for training after spinal cord injury. Phys Ther 1994;74:50-60. (Pubitemid 24020895)
99. Giangregorio L, McCartney N. Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies. J Spinal Cord Med 2006;29:489-500.
100. Gorgey AS, Shepherd C. Skeletal muscle hypertrophy and decreased intramuscular fat after unilateral resistance training in spinal cord injury: case report. J Spinal Cord Med 2010;33:90-5.
101. Paddon-Jones D, Sheffield-Moore M, Zhang XJ, Volpi E, Wolf SE, Aarsland et al. Amino acid ingestion improves muscle protein synthesis in the young and elderly. Am J Physiol Endocrinol Metab 2004;286:E321-8. (Pubitemid 38292680)
102. Paddon-Jones D, Sheffield-Moore M, Aarsland A, Wolfe RR, Ferrando AA. Exogenous amino acids stimulate human muscle anabolism without interfering with the response to mixed meal ingestion. Am J Physiol Endocrinol Metab 2005;288:E761-7. (Pubitemid 40397212)
103. Paddon-Jones D, Sheffield-Moore M, Urban RJ, Sanford AP, Aarsland A, Wolfe RR et al. Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab 2004;89:4351-8. (Pubitemid 39244437)
104. Drummond MJ, Dreyer HC, Pennings B, Fry CS, Dhanani S, Dillon EL et al. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol 2008;104:1452-61.
105. Burd NA, West DW, Moore DR, Atherton PJ, Staples AW, Prior T et al. Enhanced amino acid sensitivity of myofibrillar protein synthesis persists for up to 24 h after resistance exercise in young men. J Nutr 2011;141:568-73
106. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008;29:407-14.
107. Dobnig H. A review of the health consequences of the vitamin D deficiency pandemic. J Neurol Sci 2011;311:15-8.
108. Bauman WA, Zhong YG, Schwartz E. Vitamin D deficiency in veterans with chronic spinal cord injury. Metabolism 1995;44:1612-6. (Pubitemid 26102602)
109. Carda S, Cisari C, Invernizzi M, Bevilacqua M. Osteoporosis after stroke: a review of the causes and potential treatments. Cerebrovasc Dis 2009;28:191-200.